
Bexmarilimab
CAS No. 2259301-27-2
Bexmarilimab( —— )
Catalog No. M36875 CAS No. 2259301-27-2
Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 301 | Get Quote |
![]() ![]() |
5MG | 820 | Get Quote |
![]() ![]() |
10MG | 1102 | Get Quote |
![]() ![]() |
25MG | 1582 | Get Quote |
![]() ![]() |
50MG | 2144 | Get Quote |
![]() ![]() |
100MG | 2817 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBexmarilimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionBexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.
-
DescriptionBexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1 IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2259301-27-2
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hollmén M, et, al. Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers. Mol Cancer Ther. 2022 Jul 5;21(7):1207-1218.?
molnova catalog



related products
-
Boc-Gly-Gly-Phe-Gly-...
Boc-Gly-Gly-Phe-Gly-OH TFA is a self-assembly of N-protected and C-protected tetrapeptides and is a protease cleaved connector for antibody-drug binding (ADC).
-
Mussaenoside
Mussaenoside has anti-inflammatory action, the mechanism associated with downregulation of nuclear factor-κB.
-
3-O-Demethylarctigen...
Standard reference.